Medical Technology

@xconomy.com 3 years ago

Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity

@xconomy.com 3 years ago

Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity

@xconomy.com 4 years ago

Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?

@xconomy.com 4 years ago

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

@xconomy.com 5 years ago

GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”

@xconomy.com 5 years ago

Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More

@xconomy.com 5 years ago

Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline

@xconomy.com 5 years ago

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

@xconomy.com 5 years ago

TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push